Literature DB >> 25666907

Homozygous MYH7 R1820W mutation results in recessive myosin storage myopathy: scapuloperoneal and respiratory weakness with dilated cardiomyopathy.

Nur Yüceyar1, Özgecan Ayhan2, Hatice Karasoy1, Aslıhan Tolun3.   

Abstract

Myosin storage myopathy (MSM) is a protein aggregate myopathy caused by the accumulation of myosin in muscle fibres and results from MYH7 mutation. Although MYH7 mutation is also an established cause of variable cardiomyopathy with or without skeletal myopathy, cardiomyopathy with MSM is a rare combination. Here, we update the clinical findings in the two brothers that we previously reported as having recessively inherited MSM characterized by scapuloperoneal distribution of weakness and typical hyaline-like bodies in type 1 muscle fibres. One of the patients, weak from childhood but not severely symptomatic until 28 years of age, had an unusual combination of MSM, severe dilated cardiomyopathy, and respiratory impairment at the age of 44 years. We identified homozygous missense mutation c.5458C>T (p.R1820W) in exon 37 in these patients as the second recessive MYH7 mutation reported to date.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dilated cardiomyopathy; MYH7; Myosin storage myopathy

Mesh:

Substances:

Year:  2015        PMID: 25666907     DOI: 10.1016/j.nmd.2015.01.007

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  8 in total

1.  MYH7 mutation associated with two phenotypes of myopathy.

Authors:  Nan Li; Zhe Zhao; Hongrui Shen; Qi Bing; Xuan Guo; Jing Hu
Journal:  Neurol Sci       Date:  2017-11-24       Impact factor: 3.307

2.  Myosin storage myopathy mutations yield defective myosin filament assembly in vitro and disrupted myofibrillar structure and function in vivo.

Authors:  Meera C Viswanathan; Rick C Tham; William A Kronert; Floyd Sarsoza; Adriana S Trujillo; Anthony Cammarato; Sanford I Bernstein
Journal:  Hum Mol Genet       Date:  2017-12-15       Impact factor: 6.150

3.  Congenital myopathies are mainly associated with a mild cardiac phenotype.

Authors:  Helle Petri; Karim Wahbi; Nanna Witting; Lars Køber; Henning Bundgaard; Emna Kamoun; Geoffroy Vellieux; Tanya Stojkovic; Anthony Béhin; Pascal Laforet; John Vissing
Journal:  J Neurol       Date:  2019-03-14       Impact factor: 4.849

4.  Laing early-onset distal myopathy with subsarcolemmal hyaline bodies caused by a novel variant in the MYH7 gene.

Authors:  Luís Negrão; Rita Machado; Miguel Lourenço; Ana Fernandez-Marmiesse; Olinda Rebelo
Journal:  Acta Myol       Date:  2020-03-01

5.  Panorama of the distal myopathies.

Authors:  Marco Savarese; Jaakko Sarparanta; Anna Vihola; Per Harald Jonson; Mridul Johari; Salla Rusanen; Peter Hackman; Bjarne Udd
Journal:  Acta Myol       Date:  2020-12-01

6.  Filamentous tangles with nemaline rods in MYH2 myopathy: a novel phenotype.

Authors:  Nicolas N Madigan; Michael J Polzin; Gaofeng Cui; Teerin Liewluck; Mohammad H Alsharabati; Christopher J Klein; Anthony J Windebank; Georges Mer; Margherita Milone
Journal:  Acta Neuropathol Commun       Date:  2021-04-29       Impact factor: 7.801

7.  The Most Prevalent Freeman-Sheldon Syndrome Mutations in the Embryonic Myosin Motor Share Functional Defects.

Authors:  Jonathan Walklate; Carlos Vera; Marieke J Bloemink; Michael A Geeves; Leslie Leinwand
Journal:  J Biol Chem       Date:  2016-03-04       Impact factor: 5.157

8.  MYH7-related myopathies: clinical, histopathological and imaging findings in a cohort of Italian patients.

Authors:  C Fiorillo; G Astrea; M Savarese; D Cassandrini; G Brisca; F Trucco; M Pedemonte; R Trovato; L Ruggiero; L Vercelli; A D'Amico; G Tasca; M Pane; M Fanin; L Bello; P Broda; O Musumeci; C Rodolico; S Messina; G L Vita; M Sframeli; S Gibertini; L Morandi; M Mora; L Maggi; A Petrucci; R Massa; M Grandis; A Toscano; E Pegoraro; E Mercuri; E Bertini; T Mongini; L Santoro; V Nigro; C Minetti; F M Santorelli; C Bruno
Journal:  Orphanet J Rare Dis       Date:  2016-07-07       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.